Natural killer cell immune responses

Immunologic Research

Volumn 32, Issue 1-3, 2005, Pages 317-325

  Yokoyama, Wayne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Innate immunity; Ligands; Natural killer cells; Receptors; Viral infection

Indexed keywords

CYTOKINE; LIGAND; LY 49 H RECEPTOR; LY 49 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN; PROTEIN CMV 1; PROTEIN NKG 2 D; PROTEIN NKRP 1; RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; CELL ACTIVATION; CELL FUNCTION; CYTOKINE PRODUCTION; GENE CLUSTER; GENE LOCUS; IMMUNE RESPONSE; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; RECEPTOR AFFINITY; REVIEW; TUMOR CELL; VIRUS INFECTION;

ANIMALS; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LIGANDS; MICE; MODELS, IMMUNOLOGICAL; RECEPTORS, IMMUNOLOGIC; VIRUS DISEASES; VIRUSES;

EID: 23844555106     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:32:1-3:317     Document Type: Review

References (73)

1. Yokoyama WM: Natural killer cells; in Paul WE (ed): Fundamental Immunology. New York, Lippincott-Raven, 1999, pp 575-603.
2. Kärre K, Ljunggren HG, Piontek G, Kiessling R: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986;319:675-678.
3. Ljunggren HG, Karre K: In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244.
4. Karlhofer FM, Ribaudo RK, Yokoyama WM: MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992;358:66-70.
5. Colonna M: Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol Rev 1997;155:127-133.
6. Long EO, Burshtyn DN, Clark WP, et al: Killer cell inhibitory receptors - diversity, specificity, and function. Immunol Rev 1997;155:135-144.
7. Lanier LL: NK cell receptors. Annu Rev Immunol 1998;16:359-393.
8. Wang LL, Mehta IK, Leblanc PA, Yokoyama WM: Cutting edge: mouse natural killer cells express GP49b1, a structural homologue of human killer inhibitory receptors. J Immunol 1997;158:13-17.
9. Wang LL. Blasioli J, Plas DR, Thomas ML, Yokoyama WM: Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B. J Immunol 1999;162:1318-1323.
10. Wang LL, Chu DT, Dokun AO, Yokoyama WM: Inducible expression of the gp49B inhibitory receptor on NK cells. J Immunol 2000;164:5215-5220.
11. Yokoyama WM, Seaman WE: The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993;11:613-635.
12. Braud VM, Allen DSJ, O'Callaghan CA, et al: HLA-E binds to natural-killer-cell receptors CD94/NKG2A, B and C. Nature 1998;391:795-799.
13. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH: Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med 1998;188:1841-1848.
14. Long EO: Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999;17:875-904.
15. Yokoyama WM: Natural killer cell receptors. Curr Opin Immunol 1998;10:298-305.
16. Smith HRC, Karlhofer FM, Yokoyama WM: Ly-49 multigene family expressed by IL-2-activated NK cells. J Immunol 1994;153:1068-1079.
17. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E: Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 1997;158:5083-5086.
18. Lanier LL: On guard - activating NK cell receptors. Nat Immunol 2001;2:23-27.
19. Lanier LL: Natural killer cells: from no receptors to too many. Immunity 1997;6:371-378.
20. Yokoyama WM, Kehn PJ, Cohen DI, Shevach EM: Chromosomal location of the Ly-49 (A1, YE1/48) multigene family: genetic association with the NK 1.1 antigen. J Immunol 1990;145:2353-2358.
21. Yokoyama WM, Ryan JC, Hunter JJ, Smith HR, Stark M, Seaman WE: cDNA cloning of mouse NKR-P1 and genetic linkage with Ly-49: identification of a natural killer cell gene complex on mouse chromosome 6. J Immunol 1991;147:3229-3236.
22. Yokoyama WM, Plougastel BF: Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003;3:304-316.
23. Khalturin K, Becker M, Rinkevich B, Bosch TC: Urochordates and the origin of natural killer cells: identification of a CD94/NKR-P1-related receptor in blood cells of Botryllus. Proc Natl Acad Sci USA 2003;100:622-627.
24. Sato A, Mayer WE, Overath P, Klein J: Genes encoding putative natural killer cell C-type lectin receptors in teleostean fishes. Proc Natl Acad Sci USA 2003;100:7779-7784.
25. Brownstein DG, Gras L: Differential pathogenesis of lethal mousepox in congenic DBA/2 mice implicates natural killer cell receptor NKR-P1 in necrotizing hepatitis and the fifth component of complement in recruitment of circulating leukocytes to spleen. Am J Pathol 1997;150:1407-1420.
26. Pereira RA, Scalzo A, Simmons A: Cutting edge: a NK complex-linked locus governs acute versus latent herpes simplex virus infection of neurons. J Immunol 2001;166:5869-5873.
27. Yokoyama WM, Daniels BF, Seaman WE, Hunziker R, Margulies DH, Smith HR: A family of murine NK cell receptors specific for target cell MHC class I molecules. Semin Immunol 1995;7:89-101.
28. Bull C, Sobanov Y, Rohrdanz B, O'Brien J, Lehrach H, Hofer E: The centromeric part of the human NK gene complex: linkage of LOX-1 and LY49L with the CD94/NKG2 region. Genes Immun 2000;1:280-287.
29. Colonna M, Samaridis J: Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995;268:367, 368.
30. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO: Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995;3:801-809.
31. Idris AH, Iizuka K, Smith HRC, Scalzo AA, Yokoyama WM: Genetic control of natural killing and in vivo tumor elimination by the Chok locus. J Exp Med 1998;188:2243-2256.
32. Idris AH, Smith HRC, Mason LH, Ortaldo JH, Scalzo AA, Yokoyama WM: The natural killer cell complex genetic locus, Chok, encodes Ly49D, a target recognition receptor that activates natural killing. Proc Natl Acad Sci USA 1999;96:6330-6335.
33. Idris AH, Scalzo AA, Yokoyama WM: Close genetic linkage of Chok with the NKC-linked loci Cd94, Ly49, and Cmv1 on mouse chromosome 6. Immunogenetics 1999;49:906-908.
34. Mehta IK, Smith HRC, Wang J, Margulies DH, Yokoyama WM: A "chimeric" C57L-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor. Cell Immunol 2000;209:29-41.
35. Furukawa H, Iizuka K, Poursine-Laurent J, Shastri N, Yokoyama WM: A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta(2)-microglobulin-deficient mice. J Immunol 2002;169:126-136.
36. Matsumoto N, Ribaudo RK, Abastado J-P, Margulies DH, Yokoyama WM: The lectin-like NK cell receptor Ly-49A recognizes a carbohydrate-independent epitope on its MHC class I ligand. Immunity 1998;8:245-254.
37. Matsumoto N, Mitsuki M, Tajima K, Yokoyama WM, Yamamoto K: The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J Exp Med 2001;193:147-158.
38. Matsumoto N, Yokoyama WM, Kojima S, Yamamoto K: The NK cell MHC class I receptor Ly49A detects mutations on H-2D(d) inside and outside of the peptide binding groove. J Immunol 2001;166:4422-4428.
39. Mehta IK, Wang J, Roland J, Margulies DH, Yokoyama WM: Ly49A allelic variation and MHC class I specificity. Immunogenetics 2001;53:572-583.
40. Plougastel B, Matsumoto K, Dubbelde C, Yokoyama WM: Analysis of a 1-Mb BAC contig overlapping the mouse Nkrp1 cluster of genes: cloning of three new Nkrp1 members, Nkrp1d, Nkrp1e, and Nkrp1f. Immunogenetics 2001;53:592-598.
41. Ryan JC, Turck J, Niemi EC, Yokoyama WM, Seaman WE: Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. J Immunol 1992;149:1631-1635.
42. Bendelac A, Rivera MN, Park SH, Roark JH: Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997;15:535-562.
43. Kronenberg M, Gapin L: The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002;2:557-568.
44. Plougastel B, Dubbelde C, Yokoyama WM: Cloning of Clr, a new family of lectin-like genes localized between mouse Nkrp1a and Cd69 genes. Immunogenetics 2001;53:209-214.
45. Iizuka K, Naidenko OV, Plougastel BF, Fremont DH, Yokoyama WM: Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol 2003;4:801-807.
46. Brown MG, Scalzo AA, Stone LR, et al: Natural killer gene complex (Nkc) allelic variability in inbred mice: evidence for Nkc haplotypes. Immunogenetics 2001;53:584-591.
47. Makrigiannis AP, Pau AT, Schwartzberg PL, McVicar DW, Beck TW, Anderson SK: A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics 2002;79:437-444.
48. Nasrallah JB: Recognition and rejection of self in plant reproduction. Science 2002;296:305-308.
49. Ho EL, Heusel JW, Brown MG, Matsumoto K, Scalzo AA, Yokoyama WM: Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc Natl Acad Sci USA 1998;95:6320-6325.
50. Vance RE, Tanamachi DM, Hanke T, Raulet DH: Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol 1997;27:3236-3241.
51. Wu J, Song Y, Bakker AB, et al: An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999;285:730-732.
52. Ho EL, Carayannopoulos LN, Poursine-Laurent J, et al: Co-stimulation of multiple NK cell activation receptors by NKG2D. J Immunol 2002;169:3667-3675.
53. Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M: NKG2D recruits two distinct adapters to trigger natural killer cell activation and costimulation. Nat Immunol 2002;3:1150-1155.
54. Diefenbach A, Tomasello E, Lucas M, et al: Selective associations with signaling molecules determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol 2002;3:1142-1149.
55. Bauer S, Groh V, Wu J, et al: Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-729.
56. Cerwenka A, Bakker ABH, McClanahan T, et al: Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000;12:721-727.
57. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH: Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000;1:119-126.
58. Carayannopoulos LN, Naidenko OV, Kinder J, Ho EL, Fremont DH, Yokoyama WM: Ligands for murine NKG2D display heterogeneous binding behavior. Eur J Immunol 2002;32:597-605.
59. Carayannopoulos L, Naidenko O, Fremont D, Yokoyama WM: Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol 2002;169:4079-4083.
60. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP: Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999;17:189-220.
61. Biron CA, Byron KS, Sullivan JL: Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989;320:1731-1735.
62. Bukowski JF, Woda BA, Habu S, Okumura K, Welsh RM: Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol 1983;131:1531-1538.
63. Scalzo AA, Fitzgerald NA, Simmons A, La Vista AB, Shellam GR: Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 1990;171:1469-1483.
64. Brown MG, Dokun AO, Heusel JW, et al: Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001;292:934-937.
65. Smith HR, Chuang HH, Wang LL, Salcedo M, Heusel JW, Yokoyama WM: Nonstochastic coexpression of activation receptors on murine natural killer cells. J Exp Med 2000;191:1341-1354.
66. Smith HR, Heusel JW, Mehta IK, et al: Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002;99:8826-8831.
67. Bubic I, Wagner M, Krmpotic A, et al: Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 2004;78:7536-7544.
68. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, Yokoyama WM: Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2001;2:951-956.
69. Dorner BG, Smith HRC, French AR, et al: Coordinate expression of cytokines and chemokines by natural killer cells during murine cytomegalovirus infection. J Immunol 2004;172:3119-3131.
70. Krug A, French AR, Barchet W, et al: TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004;21:107-119.
71. French AR, Pingel JT, Wagner M, et al: Escape of mutant double-stranded DNA virus from innate immune control. Immunity 2004;20:747-756.
72. Fauci AS, Lane HC: Human immunodeficiency virus (HIV) disease: AIDS and related disorders; in Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds): Harrison's Principles of Internal Medicine. New York, McGraw-Hill, 2001, pp 1852-1913.
73. Fishman JA, Rubin RH: Infection in organ-transplant recipients. N Engl J Med 1998;338:1741-1751.